Spears Abacus Advisors LLC Bluebird Bio, Inc. Transaction History

Spears Abacus Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$16.59 - $33.89 $77,525 - $158,367	-4,673 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$27.5 - $37.92 $1,100 - $1,516	-40 Reduced 0.85%	4,673 $202,000
Q3 2020 Nov 16, 2020	SELL	$34.44 - $43.75 $162,315 - $206,193	-4,713 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$27.12 - $45.97 $127,816 - $216,656	4,713 New	4,713 $288,000

150

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $643M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Spears Abacus Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Spears Abacus Advisors LLC with notifications on news.